iBio, Inc. revenue for the last year amounted to 225.00 k USD, the most of which — 225.00 k USD — came from its highest performing source at the moment, Precision Antibodies. The greatest contribution to the revenue figure was made by United States — last year it brought iBio, Inc. 225.00 k USD, and the year before that — 2.38 M USD.